ESC 365 - Cardiovascular benefits of treatment with angiotensin receptor blockers in patients with hypertension and chronic kidney disease: a systematic review and meta-analysis

ESC Premium Access

Cardiovascular benefits of treatment with angiotensin receptor blockers in patients with hypertension and chronic kidney disease: a systematic review and meta-analysis

Session: Hypertension treatment

Topic: Pharmacotherapy

Speaker: Professor M. Burnier (Lausanne, CH)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Michel Burnier

University of Lausanne, Lausanne (Switzerland)

16 presentations

0 follower

5 more presentations in this session

New features of use of moxonidine as telomerase activator

Speaker: Doctor E. Dudinskaya (Moscow, RU)

Renal artery branch denervation: evaluation of lesion characteristics using a thermochromic liquid crystal phantom model

Speaker: Associate Professor P. Kovoor (Westmead, AU)

Regulation of cardiac ADAM-10 activity by sympathoadrenergic modulation and the role for RAGE-sRAGE balance and myocardial remodeling

Speaker: Mrs O. Zamyatkin (Saarbruecken, DE)

Calcium channel blocker monotherapy versus combination with renin-angiotensin system blockers in the development of new-onset diabetes mellitus in hypertensive Korean patients

Speaker: Professor A. Her (Chuncheon, KR)

Difference in renal parenchymal perfusion after renal denervation comparing treated vs. non-treated arteries

Speaker: Mr R. Schmieder (Munich, DE)

Access the full session

Hypertension treatment

Speakers: Professor M. Burnier, Doctor E. Dudinskaya, Associate Professor P. Kovoor, Mrs O. Zamyatkin, Professor A. Her...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources